Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Marsden

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Trials|October 16, 2021
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-helpEline Borger Rognli, Erlend Marius Aas, Robert E Drake, et al.
The Lancet. Psychiatry|October 8, 2019
Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in EnglandJohn Marsden, Martin White, Fizz Annand, et al.
Lancet (London, England)|December 7, 2016
A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspectiveRobyn Burton, Clive Henn, Don Lavoie, et al.
Drug and Alcohol Dependence|April 16, 2014
Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT)John Marsden, Brian Eastwood, Robert Ali, et al.
Drug and Alcohol Dependence|October 5, 2025
Treatment and recovery from opioid use disorder: The role of pain severity in individuals with moderate to severe painAllison N Tegge, Marco A R Ferreira, Peter M Garafola, et al.
Eclinicalmedicine|February 1, 2024
Superiority and cost-effectiveness of Individual Placement and Support versus standard employment support for people with alcohol and drug dependence: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trialJohn Marsden, Paul Anders, Claire Shaw, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2022
Correction to: Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Addiction (Abingdon, England)|June 20, 2025
Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experienceNatalie Lowry, Andrew McKechnie, Edward Day, et al.
The International Journal on Drug Policy|December 28, 2025
Scoping review of the characteristics and implementation of routine outcome monitoring and feedback for adults and young people accessing alcohol and other drug use treatmentAlison K Beck, Leanne Hides, Robert Stirling, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Trials|October 16, 2021
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-helpEline Borger Rognli, Erlend Marius Aas, Robert E Drake, et al.
The Lancet. Psychiatry|October 8, 2019
Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in EnglandJohn Marsden, Martin White, Fizz Annand, et al.
Lancet (London, England)|December 7, 2016
A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspectiveRobyn Burton, Clive Henn, Don Lavoie, et al.
Drug and Alcohol Dependence|April 16, 2014
Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT)John Marsden, Brian Eastwood, Robert Ali, et al.
Drug and Alcohol Dependence|October 5, 2025
Treatment and recovery from opioid use disorder: The role of pain severity in individuals with moderate to severe painAllison N Tegge, Marco A R Ferreira, Peter M Garafola, et al.
Eclinicalmedicine|February 1, 2024
Superiority and cost-effectiveness of Individual Placement and Support versus standard employment support for people with alcohol and drug dependence: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trialJohn Marsden, Paul Anders, Claire Shaw, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2022
Correction to: Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Addiction (Abingdon, England)|June 20, 2025
Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experienceNatalie Lowry, Andrew McKechnie, Edward Day, et al.
The International Journal on Drug Policy|December 28, 2025
Scoping review of the characteristics and implementation of routine outcome monitoring and feedback for adults and young people accessing alcohol and other drug use treatmentAlison K Beck, Leanne Hides, Robert Stirling, et al.
Pageof 15